Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: DaveAu who wrote (4137)	4/16/2000 1:38:00 PM
From: Montana Wildhack	Read Replies (1) \| Respond to of 14101

Dave, Good one. You pulled me in. I'm sitting there thinking XW...hmmm like XY line, nope. The backwards D should have been the tip off but my head is so far up my pain I'm telling everyone I don't have, that I didn't see it. Thanks for sharing that letter. So they can't say where they are with FDA because JNJ advised them against doing so. I can see that. And they're saying soon for UK finalization. I'm quite certain it's another huge drug company in the UK they're dealing with. I also recall Peter saying he didn't feel time-to-market would be that long once both these pieces complete. They are undoubtedly also gearing up for UK production at the plant we now own and I would think will begin stockpiling fairly soon. I wonder if they're hiring in Montreal? Thinking about it this weekend, I feel its probable that there is either a contingency on the JNJ deal or a disclosure clause in the deal preventing it from being announced by Dimethaid. To support this I recall Rebecca saying at the AGM that there were some tax issues remaining and no substantive issues. I had originally felt the true holdup was production volume guarantees wanted by JNJ. If JNJ commits huge sales effort investments, they need to cover their exposure to not having sufficient supply. This for me was the reason for the purchase of the plant. Not for FDA approval; but, to ensure timely capital investment in plant expansion. I don't believe the confidence was there in the previous owners but can't tell if that was operational or capital. It may also be that Dimethaid in the end simply wanted control and that portion of the revenue as has been suggested here previously. I also continue to talk to the company and I continue to be confident of their success. I would hope it gets no worse than this month where QLT as we know gets FDA approval and watches the stock go down. Now where's my helmet?? Wolf